Kemi Olugemo

Kemi Olugemo

Former Chief Medical OfficeratKorro Bio· In proxies 2024–2025

Pay in FY2025-14% from the year before · Korro Bio stock -79.0% the same year

Kemi Olugemo was paid $2.3M in FY2025 (Dec), down 14%. Korro Bio stock fell 79.0% that year.

Pay$100 in the stock at the end of FY23 → $17
Pay is from the Summary Compensation Table of each Korro Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Korro BioPublic company · 2 yr
    • Former Chief Medical Officer2024 – Present · 2 yrStock in role -73%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?